In addition, IL-22 has been implicated in hepatic inflammation, which is commonly associated with insulin resistance and non-alcoholic fatty liver disease (NAFLD)—conditions that frequently co-occur with T2DM (53). Here, IL22 is linked to metabolic dysfunction-associated steatotic liver disease.